Premium
Numerical abnormalities of chromosome 7 in interphase cell nuclei of breast carcinoma have no impact on immunohistochemically determined EGFR status
Author(s) -
SAUER TORILL,
BERAKI KAHSAI,
JEBSEN PETER W.,
NÆSS ODDVAR
Publication year - 1999
Publication title -
apmis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.909
H-Index - 88
eISSN - 1600-0463
pISSN - 0903-4641
DOI - 10.1111/j.1699-0463.1999.tb01546.x
Subject(s) - interphase , breast carcinoma , immunohistochemistry , pathology , chromosome , carcinoma , cancer research , biology , medicine , breast cancer , oncology , genetics , gene , cancer
Aim of study: To investigate the relationship between epidermal growth factor receptor (EGFR) status and numerical aberrations of chromosome 7 in breast carcinomas. Design: In situ hybridization (ISH) of interphase cell nuclei on air‐dried fine‐needle aspirates (FNAC) from 33 breast carcinomas was evaluated for numerical abnormalities in chromosome 6, 7, 12 and 17. Immunohistochemical staining of EGFR was performed on corresponding histological specimens. Results: 78% of the tumours were aneuploid by ISH. Aneusomy of chromosome 7 was found in 18 cases (60%). EGFR overexpression was observed in 30% of the carcinomas, and seven of nine were aneuploid by ISH. The same percentage of chromosome 7 aneusomy was found in both EGFR‐positive and‐negative cases. Five of seven EGFR‐positive tumours revealed aneusomy of chromosome 7. Conclusion: Numerical gain of chromosome 7 is a common finding, occurring in about 60% of breast carcinomas. Most EGFR‐positive tumours are aneuploid and show numerical gain of chromosome 7, but abnormal numbers of chromosome 7 have no impact on the EGFR status.